Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Cerilliant
McKinsey
Julphar
Federal Trade Commission
Healthtrust
McKesson
Dow

Generated: November 21, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Veliparib

« Back to Dashboard

US Patents for Veliparib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Veliparib ➤ Try a Free Trial 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors Abbott Laboratories Inc. (Abbott Park, IL) ➤ Try a Free Trial
Veliparib ➤ Try a Free Trial 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 2 Abbott Laboratories (Abbott Park, IL) ➤ Try a Free Trial
Veliparib ➤ Try a Free Trial 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 AbbVie Inc. (North Chicago, IL) ➤ Try a Free Trial
Veliparib ➤ Try a Free Trial Methods for treating ovarian cancer by inhibiting fatty acid binding proteins The University of Chicago (Chicago, IL) ➤ Try a Free Trial
Veliparib ➤ Try a Free Trial 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 AbbVie Inc. (North Chicago, IL) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Veliparib

Drugname Country Document Number Estimated Expiration Related US Patent
Veliparib Australia 2006235492 2025-04-11 ➤ Try a Free Trial
Veliparib Brazil PI0609121 2025-04-11 ➤ Try a Free Trial
Veliparib Canada 2603784 2025-04-11 ➤ Try a Free Trial
Veliparib China 101155797 2025-04-11 ➤ Try a Free Trial
Veliparib China 104961723 2025-04-11 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
US Department of Justice
UBS
Cipla
Harvard Business School
Cerilliant
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.